Southeast Xlerator Network

东南Xlerator网络

• 批准号: 10004685
• 负责人: Eugene Krentsel
• 金额: $ 146.04万
• 依托单位: XLERATEHEALTH, LLC
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10004685
• 关键词: Acceleration; Address; Adopted; Advocate; Astronomy; Award; Basic Science; Biological Sciences; Biomedical Technology; Businesses; Capital; Development; Economic Development; Ecosystem; Education; Electronics; Entrepreneurship; Evaluation; Faculty; Fostering; Funding; Goals; Grant; Health Sciences; Healthcare; Incubators; Industry; Institution; Intellectual Property; Kentucky; Knowledge; Leadership; Learning; Legal patent; Licensing; Medical Device; Medical Technology; Mentors; Outcome; Pathway interactions; Pharmacologic Substance; Phase; Privatization; Process; Puerto Rico; Research; Resources; Services; Small Business Innovation Research Grant; Small Business Technology Transfer Research; Structure; Survival Rate; Talents; Techniques; Technology; Technology Transfer; Trainers Training; Training; Training Programs; Training and Education; United States National Institutes of Health; Universities; Vision; West Virginia; commercialization; design; education resources; exhaustion; experience; improved; innovation; inter-institutional; operation; product development; programs; public-private partnership; success; technology development; tool

The Southeast XLerator Network proposes to create a networked and easily accessible regional technology transfer accelerator hub (“XLerator Hub” or “Hub”) to share best practices, disseminate education content, and offer products, services, facilities and other resources connected through both physical and online platforms for innovators and trainees in the Southeast IDeA states. Led by XLerateHealth, LLC, an SBA award-winning healthcare-focused technology accelerator, the Hub will 1) bridge the divide between great ideas and the marketplace by leveraging and connecting existing resources and unique expertise assets across all participating entities in the Southeast IDeA state region, 2) fill the gaps that constitute barriers to efficient commercialization among partner institutions, and 3) deliver the necessary resources, education, and business networks to foster and sustain a culture of entrepreneurship across the region. This project will address significant disparities and lack of access to resources, talent and capital in respective local commercialization ecosystems for biomedical technologies that are pervasive across the Southeast IDeA state region, making the rates of technology transfer and commercialization of academic research discoveries in this region suboptimal. The Hub objectives/ core functions are: 1. To improve knowledge and understanding by innovators about how technologies are brought to market. 2. To improve knowledge and understanding by accelerators and technology transfer offices about the unique commercialization pathways of various biomedical technologies 3. To facilitate access to technology/product development and commercialization resources required for early-stage technology advancement and later-stage product development 4. To help close the gap(s) in funding (a) between basic research discoveries and scientific proof of feasibility, and (b) between exhaustion of grant funding and private capital required to generate products and revenues. 5. To commercialize new innovation in pharmaceuticals, medical devices, healthcare IT and electronics, and other biomedical technologies through entrepreneurship, licensing and partnerships with established companies, and additionally commercialize the Hub’s platform, programs, and materials through access by other regions. The impact of the Hub will be increased market-ready technologies and patents, more successful startups, and increased biomedical technology acceleration.

东南 XLerator 网络提议创建一个网络化且易于访问的区域 技术转移加速器中心（“XLerator Hub”或“Hub”）分享最佳实践， 传播教育内容，提供产品、服务、设施和其他资源 通过实体和在线平台为东南部的创新者和学员建立联系 IDea 指出。由 XLerateHealth, LLC 领导，这是一家屡获 SBA 奖项的专注于医疗保健的技术 加速器，该中心将 1) 通过以下方式弥合伟大创意与市场之间的鸿沟： 利用和连接所有参与方的现有资源和独特的专业知识资产 东南 IDeA 州地区的实体，2) 填补构成高效障碍的空白 合作机构之间的商业化，以及3）提供必要的资源、教育、 和商业网络，以培育和维持整个地区的创业文化。这 该项目将解决在资源、人才和资本方面存在的巨大差异和缺乏机会的问题 各自当地普遍存在的生物医学技术商业化生态系统 整个东南 IDeA 州地区，使技术转让率和 该地区学术研究发现的商业化程度欠佳。枢纽 目标/核心职能是： 1. 提高创新者对技术如何运作的认识和理解 推向市场。 2. 提高加速器和技术转让办公室的知识和理解 关于各种生物医学技术独特的商业化途径 3. 促进获得技术/产品开发和商业化资源 早期技术进步​​和后期产品开发所需 4. 帮助缩小基础研究发现与科学研究之间的资金差距 (a) 可行性证明，以及 (b) 赠款资金用尽与私人资本之间的关系 产生产品和收入所需的。 5. 将药品、医疗器械、医疗保健 IT 领域的新创新商业化 通过创业、许可和 与老牌公司建立合作伙伴关系，并将该中心的商业化 通过其他地区访问的平台、程序和材料。 该中心的影响将是增加市场就绪的技术和专利，更加成功 初创企业，并加速生物医学技术的发展。

项目成果

Characterization and Optimization of Injectable In Situ Crosslinked Chitosan-Genipin Hydrogels.

可注射原位交联壳聚糖-京尼平水凝胶的表征和优化。

• DOI: 10.1002/mabi.202200505
• 发表时间: 2023
• 期刊: Macromolecular bioscience
• 影响因子: 4.6
• 作者: Priddy-Arrington,TylerR;Edwards,ReaganE;Colley,ClaireE;Nguyen,MarissaM;Hamilton-Adaire,Tess;Caldorera-Moore,MaryE
• 通讯作者: Caldorera-Moore,MaryE

Molecular Analysis of ZNF71 KRAB in Non-Small-Cell Lung Cancer.

• DOI: 10.3390/ijms22073752
• 发表时间: 2021-04-04
• 期刊: International journal of molecular sciences
• 影响因子: 5.6
• 作者: Ye Q;Mohamed R;Dakhlallah D;Gencheva M;Hu G;Pearce MC;Kolluri SK;Marsh CB;Eubank TD;Ivanov AV;Guo NL
• 通讯作者: Guo NL